Showing results (341-350 of 458) with videos related to

Sort By:
Pageof 46
Biomarkers in Medicine|May 19, 2010
Tau as a biomarker of neurodegenerative diseasesSusanna Schraen-Maschke, Nicolas Sergeant, Claire-Marie Dhaenens, et al.
Journal of Alzheimer'S Disease : JAD|August 17, 2013
Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389RMarie-Pierre Chaunu, Vincent Deramecourt, Valérie Buée-Scherrer, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|June 28, 2023
Kagome surface states and weak electronic correlation in vanadium-kagome metalsJianyang Ding, Ningning Zhao, Zicheng Tao, et al.
Nano Letters|April 22, 2026
Coexistence of Dirac Nodal Lines and Rashba Bands in the Topological Superconductor Candidate AuSn4Liwei Deng, Yu Huang, Tongrui Li, et al.
Journal of Neuro-Oncology|October 4, 2005
Increasing of HER2 membranar density in human glioblastoma U251MG cell line established in a new nude mice modelJean-François Mineo, Anne Bordron, Isabelle Quintin-Roué, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2019
Identification of prognostic markers in diffuse midline gliomas H3K27M-mutantCharlotte Dufour, Romain Perbet, Pierre Leblond, et al.
Acta Neuropathologica Communications|January 29, 2014
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's diseaseJohnatan Ceccom, Najat Loukh, Valérie Lauwers-Cances, et al.
Nature Materials|August 21, 2012
Quantum many-body interactions in digital oxide superlatticesEric J Monkman, Carolina Adamo, Julia A Mundy, et al.
Alzheimer'S Research & Therapy|October 7, 2025
Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathologyRaphaelle Caillierez, Clémence Leboullenger, Sarah Leclercq, et al.
Pageof 46